Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells

Seitaro Nakazawa, Ken Ichiro Sakata, Shanshan Liang, Kazuhito Yoshikawa, Hisashi Iizasa, Mitsuhiro Tada, Jun Ichi Hamada, Haruhiko Kashiwazaki, Yoshimasa Kitagawa, Yutaka Yamazaki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The tumor suppressor gene TP53 (gene) codes for a transcription factor which transactivates its target genes responsible for cell cycle arrest, DNA repair, apoptosis, and senescence. TP53 is well known to be the most frequent target of genetic mutations in nearly half of human cancers including oral squamous cell carcinoma (OSCC). Many p53 mutants including R248Q and R248W not only lose its tumor-suppressor activities, but also interfere with the functions of wild-type p53; this is so-called dominant-negative (DN) mutation. The DN p53 mutation is a predictor of poor outcome in patients with various cancers, and also a risk factor for metastatic recurrence in patients with OSCC. Recently it has been reported that DN p53 mutants acquire new oncogenic activities, which is named gain-of-function (GOF). This study aimed at determining whether R248Q and R248W were involved in OSCC cells' acquiring aggressive phenotypes, using SAS, HSC4 and Ca9-22 cell lines. First, two mutants p53, R248Q and R248W, were respectively transfected into SAS cells harboring recessive-type p53 (E336X). As a result, SAS cells expressing R248Q showed highly spreading, motile and invasive activities compared to parent or mock-transfected cells whereas those expressing R248W did not increase those activities. Secondly, in HSC4 cells harboring R248Q and Ca9-22 cells harboring R248W, expressions of the mutants p53 were inhibited by the transfection with siRNAs targeting p53. The inhibition of the mutants p53 decreased spreading, motile and invasive activities of HSC4 cells whereas it did not affect those activities of Ca9-22 cells. These findings suggest that R248Q p53 mutation, but not R248W p53 mutation, induces more motile and invasive potentials in human OSCC cells.

Original languageEnglish
Pages (from-to)37-49
Number of pages13
JournalBiomedical research (Tokyo, Japan)
Volume40
Issue number1
DOIs
Publication statusPublished - Jan 1 2019
Externally publishedYes

Fingerprint

Squamous Cell Carcinoma
Cells
Genes
Tumors
Mutation
Repair
Transcription Factors
Apoptosis
Epithelial Cells
DNA
Mouth Neoplasms
p53 Genes
Cell Cycle Checkpoints
Tumor Suppressor Genes
DNA Repair
Transfection
Neoplasms
Phenotype
Recurrence
Cell Line

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells. / Nakazawa, Seitaro; Sakata, Ken Ichiro; Liang, Shanshan; Yoshikawa, Kazuhito; Iizasa, Hisashi; Tada, Mitsuhiro; Hamada, Jun Ichi; Kashiwazaki, Haruhiko; Kitagawa, Yoshimasa; Yamazaki, Yutaka.

In: Biomedical research (Tokyo, Japan), Vol. 40, No. 1, 01.01.2019, p. 37-49.

Research output: Contribution to journalArticle

Nakazawa, S, Sakata, KI, Liang, S, Yoshikawa, K, Iizasa, H, Tada, M, Hamada, JI, Kashiwazaki, H, Kitagawa, Y & Yamazaki, Y 2019, 'Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells', Biomedical research (Tokyo, Japan), vol. 40, no. 1, pp. 37-49. https://doi.org/10.2220/biomedres.40.37
Nakazawa, Seitaro ; Sakata, Ken Ichiro ; Liang, Shanshan ; Yoshikawa, Kazuhito ; Iizasa, Hisashi ; Tada, Mitsuhiro ; Hamada, Jun Ichi ; Kashiwazaki, Haruhiko ; Kitagawa, Yoshimasa ; Yamazaki, Yutaka. / Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells. In: Biomedical research (Tokyo, Japan). 2019 ; Vol. 40, No. 1. pp. 37-49.
@article{a3589992d9614a23ae3e501fca97b827,
title = "Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells",
abstract = "The tumor suppressor gene TP53 (gene) codes for a transcription factor which transactivates its target genes responsible for cell cycle arrest, DNA repair, apoptosis, and senescence. TP53 is well known to be the most frequent target of genetic mutations in nearly half of human cancers including oral squamous cell carcinoma (OSCC). Many p53 mutants including R248Q and R248W not only lose its tumor-suppressor activities, but also interfere with the functions of wild-type p53; this is so-called dominant-negative (DN) mutation. The DN p53 mutation is a predictor of poor outcome in patients with various cancers, and also a risk factor for metastatic recurrence in patients with OSCC. Recently it has been reported that DN p53 mutants acquire new oncogenic activities, which is named gain-of-function (GOF). This study aimed at determining whether R248Q and R248W were involved in OSCC cells' acquiring aggressive phenotypes, using SAS, HSC4 and Ca9-22 cell lines. First, two mutants p53, R248Q and R248W, were respectively transfected into SAS cells harboring recessive-type p53 (E336X). As a result, SAS cells expressing R248Q showed highly spreading, motile and invasive activities compared to parent or mock-transfected cells whereas those expressing R248W did not increase those activities. Secondly, in HSC4 cells harboring R248Q and Ca9-22 cells harboring R248W, expressions of the mutants p53 were inhibited by the transfection with siRNAs targeting p53. The inhibition of the mutants p53 decreased spreading, motile and invasive activities of HSC4 cells whereas it did not affect those activities of Ca9-22 cells. These findings suggest that R248Q p53 mutation, but not R248W p53 mutation, induces more motile and invasive potentials in human OSCC cells.",
author = "Seitaro Nakazawa and Sakata, {Ken Ichiro} and Shanshan Liang and Kazuhito Yoshikawa and Hisashi Iizasa and Mitsuhiro Tada and Hamada, {Jun Ichi} and Haruhiko Kashiwazaki and Yoshimasa Kitagawa and Yutaka Yamazaki",
year = "2019",
month = "1",
day = "1",
doi = "10.2220/biomedres.40.37",
language = "English",
volume = "40",
pages = "37--49",
journal = "Biomedical Research",
issn = "0388-6107",
publisher = "Biomedical Research Foundation",
number = "1",

}

TY - JOUR

T1 - Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells

AU - Nakazawa, Seitaro

AU - Sakata, Ken Ichiro

AU - Liang, Shanshan

AU - Yoshikawa, Kazuhito

AU - Iizasa, Hisashi

AU - Tada, Mitsuhiro

AU - Hamada, Jun Ichi

AU - Kashiwazaki, Haruhiko

AU - Kitagawa, Yoshimasa

AU - Yamazaki, Yutaka

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The tumor suppressor gene TP53 (gene) codes for a transcription factor which transactivates its target genes responsible for cell cycle arrest, DNA repair, apoptosis, and senescence. TP53 is well known to be the most frequent target of genetic mutations in nearly half of human cancers including oral squamous cell carcinoma (OSCC). Many p53 mutants including R248Q and R248W not only lose its tumor-suppressor activities, but also interfere with the functions of wild-type p53; this is so-called dominant-negative (DN) mutation. The DN p53 mutation is a predictor of poor outcome in patients with various cancers, and also a risk factor for metastatic recurrence in patients with OSCC. Recently it has been reported that DN p53 mutants acquire new oncogenic activities, which is named gain-of-function (GOF). This study aimed at determining whether R248Q and R248W were involved in OSCC cells' acquiring aggressive phenotypes, using SAS, HSC4 and Ca9-22 cell lines. First, two mutants p53, R248Q and R248W, were respectively transfected into SAS cells harboring recessive-type p53 (E336X). As a result, SAS cells expressing R248Q showed highly spreading, motile and invasive activities compared to parent or mock-transfected cells whereas those expressing R248W did not increase those activities. Secondly, in HSC4 cells harboring R248Q and Ca9-22 cells harboring R248W, expressions of the mutants p53 were inhibited by the transfection with siRNAs targeting p53. The inhibition of the mutants p53 decreased spreading, motile and invasive activities of HSC4 cells whereas it did not affect those activities of Ca9-22 cells. These findings suggest that R248Q p53 mutation, but not R248W p53 mutation, induces more motile and invasive potentials in human OSCC cells.

AB - The tumor suppressor gene TP53 (gene) codes for a transcription factor which transactivates its target genes responsible for cell cycle arrest, DNA repair, apoptosis, and senescence. TP53 is well known to be the most frequent target of genetic mutations in nearly half of human cancers including oral squamous cell carcinoma (OSCC). Many p53 mutants including R248Q and R248W not only lose its tumor-suppressor activities, but also interfere with the functions of wild-type p53; this is so-called dominant-negative (DN) mutation. The DN p53 mutation is a predictor of poor outcome in patients with various cancers, and also a risk factor for metastatic recurrence in patients with OSCC. Recently it has been reported that DN p53 mutants acquire new oncogenic activities, which is named gain-of-function (GOF). This study aimed at determining whether R248Q and R248W were involved in OSCC cells' acquiring aggressive phenotypes, using SAS, HSC4 and Ca9-22 cell lines. First, two mutants p53, R248Q and R248W, were respectively transfected into SAS cells harboring recessive-type p53 (E336X). As a result, SAS cells expressing R248Q showed highly spreading, motile and invasive activities compared to parent or mock-transfected cells whereas those expressing R248W did not increase those activities. Secondly, in HSC4 cells harboring R248Q and Ca9-22 cells harboring R248W, expressions of the mutants p53 were inhibited by the transfection with siRNAs targeting p53. The inhibition of the mutants p53 decreased spreading, motile and invasive activities of HSC4 cells whereas it did not affect those activities of Ca9-22 cells. These findings suggest that R248Q p53 mutation, but not R248W p53 mutation, induces more motile and invasive potentials in human OSCC cells.

UR - http://www.scopus.com/inward/record.url?scp=85061971384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061971384&partnerID=8YFLogxK

U2 - 10.2220/biomedres.40.37

DO - 10.2220/biomedres.40.37

M3 - Article

VL - 40

SP - 37

EP - 49

JO - Biomedical Research

JF - Biomedical Research

SN - 0388-6107

IS - 1

ER -